ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $61,000 | -76.2% | 22,051 | -69.2% | 0.00% | -66.7% |
| Q1 2019 | $256,000 | +59.0% | 71,560 | +70.2% | 0.01% | +50.0% |
| Q4 2018 | $161,000 | -46.7% | 42,043 | +32.5% | 0.00% | -33.3% |
| Q3 2018 | $302,000 | -80.4% | 31,738 | -85.0% | 0.01% | -80.0% |
| Q2 2018 | $1,540,000 | +21.4% | 211,115 | -16.8% | 0.03% | +11.1% |
| Q1 2018 | $1,269,000 | -27.2% | 253,746 | -25.8% | 0.03% | -28.9% |
| Q4 2017 | $1,742,000 | +123.9% | 341,753 | +175.0% | 0.04% | +153.3% |
| Q3 2017 | $778,000 | +159.3% | 124,273 | +49.2% | 0.02% | +150.0% |
| Q2 2017 | $300,000 | +109.8% | 83,310 | +89.9% | 0.01% | +100.0% |
| Q1 2017 | $143,000 | -63.5% | 43,874 | -72.6% | 0.00% | -78.6% |
| Q4 2016 | $392,000 | – | 160,186 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |